{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:17Z","timestamp":1786980257583,"version":"build-2736575974"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00467-022-05430-7","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T13:02:52Z","timestamp":1643288572000},"page":"1981-1994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Approach to genetic testing to optimize the safety of living donor transplantation in Alport syndrome spectrum"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3816-8047","authenticated-orcid":false,"given":"Yasar","family":"Caliskan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9423-4849","authenticated-orcid":false,"given":"Krista L.","family":"Lentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"5430_CR1","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/ki.2014.326","volume":"86","author":"JH Miner","year":"2014","unstructured":"Miner JH (2014) Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome. Kidney Int 86:1081\u20131083","journal-title":"Kidney Int"},{"key":"5430_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00467-019-04282-y","volume":"35","author":"E Demir","year":"2020","unstructured":"Demir E, Caliskan Y (2020) Variations of type IV collagen-encoding genes in patients with histological diagnosis of focal segmental glomerulosclerosis. Pediatr Nephrol 35:927\u2013936","journal-title":"Pediatr Nephrol"},{"key":"5430_CR3","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s00467-020-04681-6","volume":"35","author":"X Zhang","year":"2020","unstructured":"Zhang X, Xu J, Xiao H, Yao Y, Wang H, Ren Y et al (2020) Value of electron microscopy in the pathological diagnosis of native kidney biopsies in children. Pediatr Nephrol 35:2285\u20132295","journal-title":"Pediatr Nephrol"},{"key":"5430_CR4","first-page":"916","volume":"32","author":"O Gross","year":"2015","unstructured":"Gross O, Kashtan CE, Rheault MN, Flinter F, Savige J, Miner JH et al (2015) Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome. Nephrol Dial Transplant 32:916\u2013924","journal-title":"Nephrol Dial Transplant"},{"key":"5430_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","volume":"93","author":"CE Kashtan","year":"2018","unstructured":"Kashtan CE, Ding J, Garosi G, Heidet L, Massella L, Nakanishi K et al (2018) Alport syndrome: a unified classification of genetic disorders of collagen IV alpha345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int 93:1045\u20131051","journal-title":"Kidney Int"},{"key":"5430_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/ki.2011.452","volume":"81","author":"J Temme","year":"2012","unstructured":"Temme J, Peters F, Lange K, Pirson Y, Heidet L, Torra R et al (2012) Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations. Kidney Int 81:779\u2013783","journal-title":"Kidney Int"},{"key":"5430_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000166914","volume":"5","author":"FE Dische","year":"1985","unstructured":"Dische FE, Weston MJ, Parsons V (1985) Abnormally thin glomerular basement membranes associated with hematuria, proteinuria or renal failure in adults. Am J Nephrol 5:103\u2013109","journal-title":"Am J Nephrol"},{"key":"5430_CR8","first-page":"S29","volume":"49","author":"C Antignac","year":"1995","unstructured":"Antignac C (1995) Molecular genetics of basement membranes: the paradigm of Alport syndrome. Kidney Int Suppl 49:S29\u2013S33","journal-title":"Kidney Int Suppl"},{"key":"5430_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1806891","volume":"380","author":"EE Groopman","year":"2019","unstructured":"Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H et al (2019) Diagnostic utility of exome sequencing for kidney disease. N Engl J Med 380:142\u2013151","journal-title":"N Engl J Med"},{"key":"5430_CR10","first-page":"299","volume":"38","author":"J Gobel","year":"1992","unstructured":"Gobel J, Olbricht CJ, Offner G, Helmchen U, Repp H, Koch KM et al (1992) Kidney transplantation in Alport\u2019s syndrome: long-term outcome and allograft anti-GBM nephritis. Clin Nephrol 38:299\u2013304","journal-title":"Clin Nephrol"},{"key":"5430_CR11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/00007890-199111000-00013","volume":"52","author":"E Peten","year":"1991","unstructured":"Peten E, Pirson Y, Cosyns JP, Squifflet JP, Alexandre GP, Noel LH et al (1991) Outcome of thirty patients with Alport\u2019s syndrome after renal transplantation. Transplantation 52:823\u2013826","journal-title":"Transplantation"},{"key":"5430_CR12","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.2215\/CJN.02190312","volume":"7","author":"J Temme","year":"2012","unstructured":"Temme J, Kramer A, Jager KJ, Lange K, Peters F, Muller GA et al (2012) Outcomes of male patients with Alport syndrome undergoing renal replacement therapy. Clin J Am Soc Nephrol 7:1969\u20131976","journal-title":"Clin J Am Soc Nephrol"},{"key":"5430_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1053\/ajkd.2002.31997","volume":"39","author":"MC Byrne","year":"2002","unstructured":"Byrne MC, Budisavljevic MN, Fan Z, Self SE, Ploth DW (2002) Renal transplant in patients with Alport\u2019s syndrome. Am J Kidney Dis 39:769\u2013775","journal-title":"Am J Kidney Dis"},{"key":"5430_CR14","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/BF00868709","volume":"9","author":"CE Kashtan","year":"1995","unstructured":"Kashtan CE, McEnery PT, Tejani A, Stablein DM (1995) Renal allograft survival according to primary diagnosis: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 9:679\u2013684","journal-title":"Pediatr Nephrol"},{"key":"5430_CR15","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.transproceed.2015.04.025","volume":"47","author":"VT Yilmaz","year":"2015","unstructured":"Yilmaz VT, Dinckan A, Yilmaz F, Suleymanlar G, Kocak H (2015) Outcomes of renal transplantation in patients with Alport syndrome. Transplant Proc 47:1377\u20131381","journal-title":"Transplant Proc"},{"key":"5430_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ekir.2018.01.008","volume":"3","author":"V Gillion","year":"2018","unstructured":"Gillion V, Dahan K, Cosyns JP, Hilbert P, Jadoul M, Goffin E et al (2018) Genotype and outcome after kidney transplantation in Alport syndrome. Kidney Int Rep 3:652\u2013660","journal-title":"Kidney Int Rep"},{"key":"5430_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12882-018-1052-9","volume":"19","author":"A Katsuma","year":"2018","unstructured":"Katsuma A, Nakada Y, Yamamoto I, Horita S, Furusawa M, Unagami K et al (2018) Long-term survival in Japanese renal transplant recipients with Alport syndrome: a retrospective study. BMC Nephrol 19:249","journal-title":"BMC Nephrol"},{"key":"5430_CR18","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1093\/ndt\/gfab168","volume":"36","author":"Y Caliskan","year":"2021","unstructured":"Caliskan Y, Karahan G, Akgul SU, Mirioglu S, Ozluk Y, Yazici H et al (2021) LIMS1 risk genotype and T-cell mediated rejection in kidney transplant recipients. Nephrol Dial Transplant 36:2120\u20132129","journal-title":"Nephrol Dial Transplant"},{"key":"5430_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1681\/ASN.2012020148","volume":"24","author":"J Savige","year":"2013","unstructured":"Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F (2013) Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol 24:364\u2013375","journal-title":"J Am Soc Nephrol"},{"key":"5430_CR20","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1681\/ASN.V7112288","volume":"7","author":"BL Kasiske","year":"1996","unstructured":"Kasiske BL, Ravenscraft M, Ramos EL, Gaston RS, Bia MJ, Danovitch GM (1996) The evaluation of living renal transplant donors: clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 7:2288\u20132313","journal-title":"J Am Soc Nephrol"},{"key":"5430_CR21","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrneph.2010.122","volume":"6","author":"P Niaudet","year":"2010","unstructured":"Niaudet P (2010) Living donor kidney transplantation in patients with hereditary nephropathies. Nat Rev Nephrol 6:736\u2013743","journal-title":"Nat Rev Nephrol"},{"key":"5430_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ki.2013.460","volume":"86","author":"G Mjoen","year":"2014","unstructured":"Mjoen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Oyen O et al (2014) Long-term risks for kidney donors. Kidney Int 86:162\u2013167","journal-title":"Kidney Int"},{"key":"5430_CR23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/jama.2013.285141","volume":"311","author":"AD Muzaale","year":"2014","unstructured":"Muzaale AD, Massie AB, Wang M et al (2014) Risk of end-stage renal disease following live kidney donation. JAMA 311:579\u2013586","journal-title":"JAMA"},{"key":"5430_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1510491","volume":"374","author":"ME Grams","year":"2016","unstructured":"Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR et al (2016) Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med 374:411\u2013421","journal-title":"N Engl J Med"},{"key":"5430_CR25","first-page":"S1","volume":"101","author":"KL Lentine","year":"2017","unstructured":"Lentine KL, Kasiske BL, Levey AS, Adams PL, Alberu J, Bakr MA et al (2017) KDIGO clinical practice guideline on the evaluation and care of living kidney donors. Transplantation 101:S1\u2013S109","journal-title":"Transplantation"},{"key":"5430_CR26","doi-asserted-by":"crossref","first-page":"450471","DOI":"10.1155\/2012\/450471","volume":"2012","author":"Y Caliskan","year":"2012","unstructured":"Caliskan Y, Yildiz A (2012) Evaluation of the medically complex living kidney donor. J Transplant 2012:450471","journal-title":"J Transplant"},{"key":"5430_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"JP Jais","year":"2000","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A et al (2000) X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol 11:649\u2013657","journal-title":"J Am Soc Nephrol"},{"key":"5430_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1681\/ASN.V52161","volume":"5","author":"J Ding","year":"1994","unstructured":"Ding J, Zhou J, Tryggvason K, Kashtan CE (1994) COL4A5 deletions in three patients with Alport syndrome and posttransplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 5:161\u2013168","journal-title":"J Am Soc Nephrol"},{"key":"5430_CR29","first-page":"508","volume":"116","author":"CE Kashtan","year":"1990","unstructured":"Kashtan CE, Butkowski RJ, Kleppel MM, First MR, Michael AF (1990) Posttransplant anti-glomerular basement membrane nephritis in related males with Alport syndrome. J Lab Clin Med 116:508\u2013515","journal-title":"J Lab Clin Med"},{"key":"5430_CR30","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/S0272-6386(98)70135-0","volume":"32","author":"DF O'Dea","year":"1998","unstructured":"O\u2019Dea DF, Murphy SW, Hefferton D, Parfrey PS (1998) Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study. Am J Kidney Dis 32:794\u2013801","journal-title":"Am J Kidney Dis"},{"key":"5430_CR31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0272-6386(12)80266-6","volume":"21","author":"BI Freedman","year":"1993","unstructured":"Freedman BI, Spray BJ, Tuttle AB, Buckalew VM Jr (1993) The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 21:387\u2013393","journal-title":"Am J Kidney Dis"},{"key":"5430_CR32","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/ki.1985.63","volume":"27","author":"J Feingold","year":"1985","unstructured":"Feingold J, Bois E, Chompret A, Broyer M, Gubler MC, Grunfeld JP (1985) Genetic heterogeneity of Alport syndrome. Kidney Int 27:672\u2013677","journal-title":"Kidney Int"},{"key":"5430_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ncpneph0671","volume":"4","author":"MC Gubler","year":"2008","unstructured":"Gubler MC (2008) Inherited diseases of the glomerular basement membrane. Nat Clin Pract Nephrol 4:24\u201337","journal-title":"Nat Clin Pract Nephrol"},{"key":"5430_CR34","first-page":"314","volume":"16","author":"C Pescucci","year":"2003","unstructured":"Pescucci C, Longo I, Bruttini M, Mari F, Renieri A (2003) Type-IV collagen related diseases. J Nephrol 16:314\u2013316","journal-title":"J Nephrol"},{"key":"5430_CR35","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1681\/ASN.2020071065","volume":"32","author":"J Gibson","year":"2021","unstructured":"Gibson J, Fieldhouse R, Chan MMY, Sadeghi-Alavijeh O, Burnett L, Izzi V et al (2021) Prevalence estimates of predicted pathogenic COL4A3-COL4A5 variants in a population sequencing database and their implications for Alport syndrome. J Am Soc Nephrol 32:2273\u20132290","journal-title":"J Am Soc Nephrol"},{"key":"5430_CR36","first-page":"1192","volume":"58","author":"A Renieri","year":"1996","unstructured":"Renieri A, Bruttini M, Galli L, Zanelli P, Neri T, Rossetti S et al (1996) X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. Am J Hum Genet 58:1192\u20131204","journal-title":"Am J Hum Genet"},{"key":"5430_CR37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/humu.23364","volume":"39","author":"S Daga","year":"2018","unstructured":"Daga S, Baldassarri M, Lo Rizzo C, Fallerini C, Imperatore V, Longo I et al (2018) Urine-derived podocytes-lineage cells: a promising tool for precision medicine in Alport syndrome. Hum Mutat 39:302\u2013314","journal-title":"Hum Mutat"},{"key":"5430_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ejhg.2015.113","volume":"24","author":"XJ Fu","year":"2016","unstructured":"Fu XJ, Nozu K, Kaito H, Ninchoji T, Morisada N, Nakanishi K et al (2016) Somatic mosaicism and variant frequency detected by next-generation sequencing in X-linked Alport syndrome. Eur J Hum Genet 24:387\u2013391","journal-title":"Eur J Hum Genet"},{"key":"5430_CR39","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","volume":"14","author":"JP Jais","year":"2003","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A et al (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study. J Am Soc Nephrol 14:2603\u20132610","journal-title":"J Am Soc Nephrol"},{"key":"5430_CR40","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1093\/ndt\/gfn635","volume":"24","author":"O Gross","year":"2009","unstructured":"Gross O, Weber M, Fries JW, Muller GA (2009) Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome. Nephrol Dial Transplant 24:1626\u20131630","journal-title":"Nephrol Dial Transplant"},{"key":"5430_CR41","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1097\/TP.0000000000002089","volume":"102","author":"C Choi","year":"2018","unstructured":"Choi C, Ahn S, Min SK, Ha J, Ahn C, Kim Y et al (2018) Midterm outcome of kidney transplantation from donors with thin basement membrane nephropathy. Transplantation 102:e180\u2013e184","journal-title":"Transplantation"},{"key":"5430_CR42","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/ndt\/gfn779","volume":"24","author":"CE Kashtan","year":"2009","unstructured":"Kashtan CE (2009) Women with Alport syndrome: risks and rewards of kidney donation. Nephrol Dial Transplant 24:1369\u20131370","journal-title":"Nephrol Dial Transplant"},{"key":"5430_CR43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2147\/IJNRD.S150539","volume":"11","author":"CE Kashtan","year":"2018","unstructured":"Kashtan CE (2018) Renal transplantation in patients with Alport syndrome: patient selection, outcomes, and donor evaluation. Int J Nephrol Renovasc Dis 11:267\u2013270","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"5430_CR44","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00467-019-04241-7","volume":"35","author":"MN Rheault","year":"2020","unstructured":"Rheault MN, Savige J, Randles MJ, Weinstock A, Stepney M, Turner AN et al (2020) The importance of clinician, patient and researcher collaborations in Alport syndrome. Pediatr Nephrol 35:733\u2013742","journal-title":"Pediatr Nephrol"},{"key":"5430_CR45","first-page":"267","volume":"23","author":"JP Grunfeld","year":"1985","unstructured":"Grunfeld JP, Noel LH, Hafez S, Droz D (1985) Renal prognosis in women with hereditary nephritis. Clin Nephrol 23:267\u2013271","journal-title":"Clin Nephrol"},{"key":"5430_CR46","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1681\/ASN.V75702","volume":"7","author":"N Heiskari","year":"1996","unstructured":"Heiskari N, Zhang X, Zhou J, Leinonen A, Barker D, Gregory M et al (1996) Identification of 17 mutations in ten exons in the COL4A5 collagen gene, but no mutations found in four exons in COL4A6: a study of 250 patients with hematuria and suspected of having Alport syndrome. J Am Soc Nephrol 7:702\u2013709","journal-title":"J Am Soc Nephrol"},{"key":"5430_CR47","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.gene.2013.05.045","volume":"526","author":"S Beicht","year":"2013","unstructured":"Beicht S, Strobl-Wildemann G, Rath S, Wachter O, Alberer M, Kaminsky E et al (2013) Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome. Gene 526:474\u2013477","journal-title":"Gene"},{"key":"5430_CR48","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10157-016-1352-y","volume":"21","author":"K Yokota","year":"2017","unstructured":"Yokota K, Nozu K, Minamikawa S, Yamamura T, Nakanishi K, Kaneda H et al (2017) Female X-linked Alport syndrome with somatic mosaicism. Clin Exp Nephrol 21:877\u2013883","journal-title":"Clin Exp Nephrol"},{"key":"5430_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1681\/ASN.V12197","volume":"12","author":"L Heidet","year":"2001","unstructured":"Heidet L, Arrondel C, Forestier L, Cohen-Solal L, Mollet G, Gutierrez B et al (2001) Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J Am Soc Nephrol 12:97\u2013106","journal-title":"J Am Soc Nephrol"},{"key":"5430_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/ng0994-77","volume":"8","author":"T Mochizuki","year":"1994","unstructured":"Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y et al (1994) Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8:77\u201381","journal-title":"Nat Genet"},{"key":"5430_CR51","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1093\/ndt\/gfh435","volume":"19","author":"R Torra","year":"2004","unstructured":"Torra R, Tazon-Vega B, Ars E, Ballarin J (2004) Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure. Nephrol Dial Transplant 19:2429\u20132432","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 10","key":"5430_CR52","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1034\/j.1399-0012.17.s10.5.x","volume":"17","author":"K Sakai","year":"2003","unstructured":"Sakai K, Muramatsu M, Ogiwara H, Kawamura T, Arai K, Aikawa A et al (2003) Living related kidney transplantation in a patient with autosomal-recessive Alport syndrome. Clin Transplant 17(Suppl 10):4\u20138","journal-title":"Clin Transplant"},{"key":"5430_CR53","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1046\/j.1523-1755.2002.00379.x","volume":"61","author":"I Longo","year":"2002","unstructured":"Longo I, Porcedda P, Mari F, Giachino D, Meloni I, Deplano C et al (2002) COL4A3\/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. Kidney Int 61:1947\u20131956","journal-title":"Kidney Int"},{"key":"5430_CR54","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00467-015-3067-9","volume":"30","author":"R Lennon","year":"2015","unstructured":"Lennon R, Stuart HM, Bierzynska A, Randles MJ, Kerr B, Hillman KA et al (2015) Coinheritance of COL4A5 and MYO1E mutations accentuate the severity of kidney disease. Pediatr Nephrol 30:1459\u20131465","journal-title":"Pediatr Nephrol"},{"key":"5430_CR55","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12882-019-1258-5","volume":"20","author":"S Daga","year":"2019","unstructured":"Daga S, Fallerini C, Furini S, Pecoraro C, Scolari F, Ariani F et al (2019) Non-collagen genes role in digenic Alport syndrome. BMC Nephrol 20:70","journal-title":"BMC Nephrol"},{"key":"5430_CR56","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12882-018-0906-5","volume":"19","author":"K Voskarides","year":"2018","unstructured":"Voskarides K, Papagregoriou G, Hadjipanagi D, Petrou I, Savva I, Elia A et al (2018) COL4A5 and LAMA5 variants co-inherited in familial hematuria: digenic inheritance or genetic modifier effect? BMC Nephrol 19:114","journal-title":"BMC Nephrol"},{"key":"5430_CR57","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semnephrol.2005.01.012","volume":"25","author":"FL Ierino","year":"2005","unstructured":"Ierino FL, Kanellis J (2005) Thin basement membrane nephropathy and renal transplantation. Semin Nephrol 25:184\u2013187","journal-title":"Semin Nephrol"},{"key":"5430_CR58","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1097\/01.tp.0000181098.56617.b2","volume":"80","author":"R Koushik","year":"2005","unstructured":"Koushik R, Garvey C, Manivel JC, Matas AJ, Kasiske BL (2005) Persistent, asymptomatic, microscopic hematuria in prospective kidney donors. Transplantation 80:1425\u20131429","journal-title":"Transplantation"},{"key":"5430_CR59","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1523-1755.2004.00453.x","volume":"65","author":"YY Wang","year":"2004","unstructured":"Wang YY, Rana K, Tonna S, Lin T, Sin L, Savige J (2004) COL4A3 mutations and their clinical consequences in thin basement membrane nephropathy (TBMN). Kidney Int 65:786\u2013790","journal-title":"Kidney Int"},{"key":"5430_CR60","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/TP.0b013e318247a7b7","volume":"93","author":"PA Andrews","year":"2012","unstructured":"Andrews PA, Burnapp L, Manas D, Bradley JA, Dudley C, British Transplantation Society; Renal Association (2012) Summary of the British Transplantation Society\/Renal Association U.K. guidelines for living donor kidney transplantation. Transplantation 93:666\u2013673","journal-title":"Transplantation"},{"key":"5430_CR61","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/TP.0000000000000918","volume":"99","author":"R Richardson","year":"2015","unstructured":"Richardson R, Connelly M, Dipchand C, Garg AX, Ghanekar A, Houde I et al (2015) Kidney paired donation protocol for participating donors 2014. Transplantation 99:S1\u2013S88","journal-title":"Transplantation"},{"key":"5430_CR62","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41431-021-00858-1","volume":"29","author":"J Savige","year":"2021","unstructured":"Savige J, Storey H, Watson E, Hertz JM, Deltas C, Renieri A et al (2021) Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria. Eur J Hum Genet 29:1186\u20131197","journal-title":"Eur J Hum Genet"},{"key":"5430_CR63","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ndt\/gfv325","volume":"31","author":"C Gast","year":"2016","unstructured":"Gast C, Pengelly RJ, Lyon M, Bunyan DJ, Seaby EG, Graham N et al (2016) Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis. Nephrol Dial Transplant 31:961\u2013970","journal-title":"Nephrol Dial Transplant"},{"key":"5430_CR64","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ki.2014.305","volume":"86","author":"AF Malone","year":"2014","unstructured":"Malone AF, Phelan PJ, Hall G, Cetincelik U, Homstad A, Alonso AS et al (2014) Rare hereditary COL4A3\/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int 86:1253\u20131259","journal-title":"Kidney Int"},{"key":"5430_CR65","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2215\/CJN.08750718","volume":"14","author":"T Yao","year":"2019","unstructured":"Yao T, Udwan K, John R, Rana A, Haghighi A, Xu L et al (2019) Integration of genetic testing and pathology for the diagnosis of adults with FSGS. Clin J Am Soc Nephrol 14:213\u2013223","journal-title":"Clin J Am Soc Nephrol"},{"key":"5430_CR66","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.ekir.2020.04.011","volume":"5","author":"Y Li","year":"2020","unstructured":"Li Y, Groopman EE, D\u2019Agati V, Prakash S, Zhang J, Mizerska-Wasiak M et al (2020) Type IV collagen mutations in familial IgA nephropathy. Kidney Int Rep 5:1075\u20131078","journal-title":"Kidney Int Rep"},{"key":"5430_CR67","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/ckj\/sfu033","volume":"7","author":"AM Sevillano","year":"2014","unstructured":"Sevillano AM, Gutierrez E, Morales E, Hernandez E, Molina M, Gonzalez E et al (2014) Multiple kidney cysts in thin basement membrane disease with proteinuria and kidney function impairment. Clin Kidney J 7:251\u2013256","journal-title":"Clin Kidney J"},{"key":"5430_CR68","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ekir.2019.09.004","volume":"5","author":"A Gulati","year":"2020","unstructured":"Gulati A, Sevillano AM, Praga M, Gutierrez E, Alba I, Dahl NK et al (2020) Collagen IV gene mutations in adults with bilateral renal cysts and CKD. Kidney Int Rep 5:103\u2013108","journal-title":"Kidney Int Rep"},{"key":"5430_CR69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM et al (2015) A global reference for human genetic variation. Nature 526:68\u201374","journal-title":"Nature"},{"key":"5430_CR70","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424","journal-title":"Genet Med"},{"key":"5430_CR71","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","volume":"10","author":"CS Richards","year":"2008","unstructured":"Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR et al (2008) ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007. Genet Med 10:294\u2013300","journal-title":"Genet Med"},{"key":"5430_CR72","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.kint.2017.06.013","volume":"92","author":"AJ Mallett","year":"2017","unstructured":"Mallett AJ, McCarthy HJ, Ho G, Holman K, Farnsworth E, Patel C et al (2017) Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders. Kidney Int 92:1493\u20131506","journal-title":"Kidney Int"},{"key":"5430_CR73","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ajhg.2018.02.019","volume":"102","author":"N Shah","year":"2018","unstructured":"Shah N, Hou YC, Yu HC, Sainger R, Caskey CT, Venter JC et al (2018) Identification of misclassified ClinVar variants via disease population prevalence. Am J Hum Genet 102:609\u2013619","journal-title":"Am J Hum Genet"},{"key":"5430_CR74","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/gim.2016.40","volume":"18","author":"JE Hunter","year":"2016","unstructured":"Hunter JE, Irving SA, Biesecker LG, Buchanan A, Jensen B, Lee K et al (2016) A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation. Genet Med 18:1258\u20131268","journal-title":"Genet Med"},{"key":"5430_CR75","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1399-3046.2006.00528.x","volume":"10","author":"CE Kashtan","year":"2006","unstructured":"Kashtan CE (2006) Renal transplantation in patients with Alport syndrome. Pediatr Transplant 10:651\u2013657","journal-title":"Pediatr Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05430-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-022-05430-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05430-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T18:55:35Z","timestamp":1674586535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-022-05430-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":75,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["5430"],"URL":"https:\/\/doi.org\/10.1007\/s00467-022-05430-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"assertion":[{"value":"23 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Krista Lentine serves as a consultant for CareDx, Inc. and served on the speaker bureau of Sanofi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}